Charles joined the China Kadoorie Biobank research unit as a DPhil student in October 2023. Under the supervision of Professors Huaidong Du, Iona Millwood, and Derrick Bennett, his research examines potential therapeutic targets for glaucoma and other eye diseases using proteogenomic data from prospective biobank studies.
Charles earned a BA (Hons) in Molecular and Cell Biology from the University of California, Berkeley. There, he had the opportunity to contribute to an international research collaboration on optimizing infectious disease surveillance networks that was led by the UC Berkeley School of Public Health and the Chinese Center for Disease Control and Prevention (China CDC), where he was hosted for three summers as a visiting researcher in Chengdu, Sichuan. Afterwards, Charles joined the data science and analytics team of the American Academy of Ophthalmology to conduct observational research on key topics in ophthalmology and eye care using a multimillion-patient national ocular disease registry.
Shifts in ophthalmic care utilization during the COVID-19 pandemic in the US.
Li C. et al, (2023), Commun Med (Lond), 3
Prevalence and Risk Factors of Blindness Among Primary Angle Closure Glaucoma Patients in the United States: An IRIS® Registry Analysis.
Shah SN. et al, (2023), Am J Ophthalmol
The impact of month and season on the incidence of giant cell arteritis: an Intelligent Research in Sight (IRIS) Registry analysis.
Wladis EJ. et al, (2023), Graefes Arch Clin Exp Ophthalmol
Vitreoretinopathy-Associated Pediatric Retinal Detachment Treatment Outcomes: IRIS® Registry (Intelligent Research in Sight) Analysis.
Belin PJ. et al, (2023), Ophthalmol Sci, 3
Shifts in Care Utilization Patterns During the COVID-19 Pandemic: A High-Dimensional Study of Presentations for Ophthalmic Conditions in the US
Li C. et al, (2023)